Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corporation    EW

EDWARDS LIFESCIENCES CORPORATION (EW)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Edwards Lifesciences Corp : Edwards Lifesciences to Host Earnings Conference Call on April 24, 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:28pm CEST

IRVINE, CA, April 16, 2012

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 392053. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EDWARDS LIFESCIENCES CORPO
06/21EDWARDS LIFESCIENCES : An Application for the Trademark "DEDICATED TO BRIGHTER F..
AQ
06/21EDWARDS LIFESCIENCES : Patent Issued for Finger-Mounted Surgical Instruments and..
AQ
06/15EDWARDS LIFESCIENCES CORP : Entry into a Material Definitive Agreement, Financia..
AQ
06/14EDWARDS LIFESCIENCES : Patent Issued for Expandable Sheath for Introducing an En..
AQ
06/14EDWARDS LIFESCIENCES : Researchers Submit Patent Application, "Percutaneous Leaf..
AQ
06/14EDWARDS LIFESCIENCES : "Pre-Stressing and Capping Bioprosthetic Tissue" in Paten..
AQ
06/08CLOT MANAGEMENT DEVICES MARKET QUALI : Clot Management Devices market. Key compa..
AQ
06/08EDWARDS LIFESCIENCES CORPORATION (NY : EW) Files An 8-K Other Events
AQ
06/07EDWARDS LIFESCIENCES CORP : Other Events, Financial Statements and Exhibits (for..
AQ
06/07EDWARDS LIFESCIENCES : Patent Issued for Bi-Directional Cannula (USPTO 9981119)
AQ
More news
News from SeekingAlpha
06/13Headlines Don't Determine Stock Prices - Cramer's Mad Money (6/12/18) 
06/06Don't Let Go Of Hasbro - Cramer's Lightning Round (6/5/18) 
05/31Premarket analyst action - healthcare 
05/12EDWARDS LIFESCIENCES : Treating The #1 Killer In America 
05/01Edwards launches $400M accelerated share buyback program 
Financials ($)
Sales 2018 3 849 M
EBIT 2018 1 165 M
Net income 2018 943 M
Finance 2018 288 M
Yield 2018 -
P/E ratio 2018 34,11
P/E ratio 2019 29,89
EV / Sales 2018 8,34x
EV / Sales 2019 7,45x
Capitalization 32 376 M
Chart EDWARDS LIFESCIENCES CORPO
Duration : Period :
Edwards Lifesciences Corpo Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Technical analysis trends EDWARDS LIFESCIENCES CORPO
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 148 $
Spread / Average Target -4,0%
EPS Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John P. McGrath Vice President-Quality, Regulatory & Clinical
William J. Link Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES CORPORATION36.55%32 376
THERMO FISHER SCIENTIFIC10.56%84 460
DANAHER CORPORATION6.81%69 878
INTUITIVE SURGICAL33.57%55 356
BOSTON SCIENTIFIC CORPORATION28.76%44 044
ILLUMINA30.78%42 004